5N2K
Structure of unbound Briakinumab FAb
Functional Information from PDB Data
| site_id | AC1 |
| Number of Residues | 6 |
| Details | binding site for residue EDO I 301 |
| Chain | Residue |
| I | GLN38 |
| I | LYS46 |
| I | ARG62 |
| I | PHE63 |
| I | GLU82 |
| I | ASP83 |
| site_id | AC2 |
| Number of Residues | 4 |
| Details | binding site for Di-peptide PCA G 1 and SER G 2 |
| Chain | Residue |
| G | HOH346 |
| G | VAL3 |
| G | ASN28 |
| G | ASP93 |
| site_id | AC3 |
| Number of Residues | 5 |
| Details | binding site for Di-peptide PCA J 1 and VAL J 2 |
| Chain | Residue |
| J | GLN3 |
| J | SER25 |
| J | GLY26 |
| J | PHE27 |
| J | ASN104 |
Functional Information from PROSITE/UniProt
| site_id | PS00290 |
| Number of Residues | 7 |
| Details | IG_MHC Immunoglobulins and major histocompatibility complex proteins signature. YICNVNH |
| Chain | Residue | Details |
| B | TYR196-HIS202 | |
| J | TYR196-HIS202 | |
| A | TYR196-HIS202 | |
| G | TYR196-HIS202 |
